ML25045A060
| ML25045A060 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 02/14/2025 |
| From: | Bartelme J SHINE Technologies |
| To: | Office of Nuclear Reactor Regulation, Document Control Desk |
| References | |
| 2025-SMT-0004 | |
| Download: ML25045A060 (1) | |
Text
3400 Innovation Ct.
- Janesville, WI 53546
- 877.512.6554
- www.SHINEfusion.com February 14, 2025 2025-SMT-0004 10 CFR 50.4 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555
References:
(1)
NRC letter to SHINE Technologies, LLC, SHINE Technologies, LLC -
Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility Related to the Receipt and Possession of Contained Special Nuclear Material (EPID No. L-2022--LLA-0163), dated May 5, 2023 (ML23087A227)
(2)
SHINE Technologies, LLC letter to NRC, Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001, dated August 15, 2024 (ML24228A138)
Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 Pursuant to the License Conditions described in Section 3.D.(1) of the SHINE Technologies, LLC (SHINE) Construction Permit as amended (Reference 1), SHINE is required to submit a periodic report providing the NRC staff with information related to nuclear criticality safety and radiation protection. Since the submittal of SHINEs previous periodic report (Reference 2),
there is no new or different information for SHINE to report on these topics.
If you have any questions, please contact me at 608/210-1735.
I declare under the penalty of perjury that the foregoing is true and correct.
Executed on February 14, 2025.
Very truly yours, Jeff Bartelme Senior Director of Regulatory Affairs SHINE Technologies, LLC Docket No. 50-608 cc:
Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health